Search - tctmd.com

Displaying 1 - 20 of 119

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Caitlin E. Cox

October 27, 2023

Presentation TCT 2023

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Presenter: Haibo Jia

October 26, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

Presenter: Matthias Bossard

October 26, 2023

Presentation TCT 2023

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

Presenter: Alessandra Laricchia

October 26, 2023

Presentation TCT 2023

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Presenter: Ae-Young Her

October 26, 2023

Presentation TCT 2023

Novel Solutions for High Bleeding Risk Patients

Presenter: Bjorn Redfors

October 26, 2023

Presentation TCT 2023

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

Presenter: Matthew Li Kam Wa

October 26, 2023

Presentation TCT 2023

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

Presenter: Teruyoshi Kume

October 26, 2023

Presentation TCT 2023

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Presenter: Jun-Won Lee

October 26, 2023

Presentation TCT 2023

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Presenter: Stephan Windecker

October 26, 2023

Advertisement

Top Endovascular News of 2023

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Novel Solutions for High Bleeding Risk Patients

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content